Sintilimab, IBI305, and chemotherapy could be a new standard of care for patients with EGFR-mutant NSCLC that progressed on an EGFR TKI.
Smokers for whom annual screening with low-dose computed tomography (LDCT) is not recommended may have a high risk for lung cancer.
Lung cancer is the leading cause of cancer deaths in the United States, but doctors have had access to a screening tool for nearly a decade that can catch it for early treatment.
Guideline-adherent care was associated with better survival, regardless of disease stage.
Detection of ctDNA and early changes in ctDNA levels may predict treatment outcomes in patients with advanced solid tumors.